| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/HIV.12421 |
| P698 | PubMed publication ID | 27578404 |
| P50 | author | Janaki Amin | Q42839711 |
| P2093 | author name string | K Ruxrungtham | |
| M G Law | |||
| S J Kerr | |||
| S Teeraananchai | |||
| P2860 | cites work | Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda | Q38869763 |
| Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study | Q41377430 | ||
| Estimating trends in life expectancy in HIV-positive individuals | Q41471847 | ||
| Survival of persons with and without HIV infection in Denmark, 1995-2005. | Q50544706 | ||
| Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia | Q57259701 | ||
| Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals | Q22242705 | ||
| Life expectancy of HIV-positive adults: a review | Q22248095 | ||
| Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860749 | ||
| Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada | Q28537704 | ||
| Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy | Q34003391 | ||
| Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. | Q34405742 | ||
| Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy? | Q34455423 | ||
| Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies | Q34667707 | ||
| Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America | Q34823231 | ||
| Estimating the impact of antiretroviral therapy: regional and global estimates of life-years gained among adults | Q35214935 | ||
| Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study | Q35316315 | ||
| Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada | Q35693918 | ||
| Mass HIV Treatment and Sex Disparities in Life Expectancy: Demographic Surveillance in Rural South Africa | Q35850330 | ||
| The Missing Men: HIV Treatment Scale-Up and Life Expectancy in Sub-Saharan Africa | Q35850422 | ||
| Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies | Q36285986 | ||
| Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. | Q37439827 | ||
| Life expectancy living with HIV: recent estimates and future implications | Q38065781 | ||
| Life expectancy in the immune recovery era: the evolving scenario of the HIV epidemic in northern Italy | Q38422670 | ||
| P433 | issue | 4 | |
| P921 | main subject | life expectancy | Q188419 |
| meta-analysis | Q815382 | ||
| anti-retroviral agent | Q50430310 | ||
| P304 | page(s) | 256-266 | |
| P577 | publication date | 2016-08-31 | |
| P1433 | published in | HIV Medicine | Q15756376 |
| P1476 | title | Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis | |
| P478 | volume | 18 |
| Q59325063 | 'They care rudely!': resourcing and relational health system factors that influence retention in care for people living with HIV in Zambia |
| Q92604549 | A new grounded theory model of sexual adjustment to HIV: facilitators of sexual adjustment and recommendations for clinical practice |
| Q94587776 | A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapy |
| Q56991795 | Achieving the fourth 90: healthy aging for people living with HIV |
| Q89984968 | Adherence to Combination Antiretroviral Therapy among Pregnant Women Enrolled in a HIV Prevention Program in Rural North-central Nigeria |
| Q57785690 | An evaluation of the innovative potentials of a HIV pilot exploring medical pluralism in rural South Africa |
| Q54226278 | Antiretroviral Therapy Treatment in Australia - Comparing the Australian HIV Observational Database Using a National Representative Database of Prescription Data. |
| Q92390527 | Associations of regional amyloid-β plaque and phospho-tau pathology with biological factors and neuropsychological functioning among HIV-infected adults |
| Q94554842 | Bone Mineral Density, Body Composition, and Mineral Homeostasis Over 24 Months in Urban South African Women With HIV Exposed to Antiretroviral Therapy |
| Q90210801 | Brain 18F-FDG PET of SIV-infected macaques after treatment interruption or initiation |
| Q90705235 | CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV |
| Q47432409 | CSF in acute and chronic infectious diseases |
| Q41929587 | Cancer screening in women living with HIV infection |
| Q57795262 | Current Strategies for Elimination of HIV-1 Latent Reservoirs Using Chemical Compounds Targeting Host and Viral Factors |
| Q38634561 | Differential Effects of Antiretroviral Drugs on Neurons In Vitro: Roles for Oxidative Stress and Integrated Stress Response. |
| Q90071250 | Evaluating Neurodevelopmental Consequences of Perinatal Exposure to Antiretroviral Drugs: Current Challenges and New Approaches |
| Q56911620 | Expert consensus statement on the science of HIV in the context of criminal law |
| Q89496410 | Exploring pathways from violence and HIV disclosure without consent to depression, social support, and HIV medication self-efficacy among women living with HIV in Metro Vancouver, Canada |
| Q96811102 | Extracellular Vesicles in Viral Infections of the Nervous System |
| Q92874752 | Extracellular Vesicles: A Possible Link between HIV and Alzheimer's Disease-Like Pathology in HIV Subjects? |
| Q91938838 | GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds |
| Q38403063 | Growing challenges for HIV programmes in Asia: clinic population trends, 2003-2013. |
| Q89547831 | HIV-1 elite controllers present a high frequency of activated regulatory T and Th17 cells |
| Q92953723 | Halogen Bond Interactions of Novel HIV-1 Protease Inhibitors (PI) (GRL-001-15 and GRL-003-15) with the Flap of Protease Are Critical for Their Potent Activity against Wild-Type HIV-1 and Multi-PI-Resistant Variants |
| Q53707006 | High Virologic Failure Rates with Maraviroc-Based Salvage Regimens Among Indian Patients: A Preliminary Analysis-Maraviroc Effectiveness in HIV-1 Subtype C. |
| Q30252460 | Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines |
| Q64278569 | Improved adherence to anti-retroviral therapy among traditionalists: reflections from rural South Africa |
| Q57023704 | Increase in HSV shedding at initiation of antiretroviral therapy (ART) and decrease in shedding over time on ART in HIV and HSV-2 infected persons |
| Q33912595 | Inflammation, Immune Activation, and Antiretroviral Therapy in HIV |
| Q57286625 | Integrating Cervical Cancer Screening Into Safer Conception Services to Improve Women's Health Outcomes: A Pilot Study at a Primary Care Clinic in South Africa. |
| Q38891475 | Knowledge of HIV-related disabilities and challenges in accessing care: Qualitative research from Zimbabwe. |
| Q93075738 | Life expectancy of HIV-positive patients after diagnosis in Iran from 1986 to 2016: A retrospective cohort study at national and sub-national levels |
| Q90644707 | Life-Expectancy Disparities Among Adults With HIV in the United States and Canada: The Impact of a Reduction in Drug- and Alcohol-Related Deaths Using the Lives Saved Simulation Model |
| Q55513048 | Lipodystrophy diagnosis in people living with HIV/AIDS: prediction and validation of sex-specific anthropometric models. |
| Q90180918 | Long-Acting Anti-HIV Drugs Targeting HIV-1 Reverse Transcriptase and Integrase |
| Q89522543 | Management of HIV-infected patients in the intensive care unit |
| Q92052925 | Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017 |
| Q91995997 | Needs must: living donor liver transplantation from an HIV-positive mother to her HIV-negative child in Johannesburg, South Africa |
| Q92856642 | Neurorestoration of Sustained Attention in a Model of HIV-1 Associated Neurocognitive Disorders |
| Q92650874 | Optimizing Treatment for Adults with HIV/AIDS in China: Successes over Two Decades and Remaining Challenges |
| Q40060225 | Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years-The Australian Positive & Peers Longevity Evaluation Study (APPLES). |
| Q91720531 | Quadruple versus triple combination antiretroviral therapies for treatment naive people with HIV: systematic review and meta-analysis of randomised controlled trials |
| Q64227157 | Quantitative ultrasonometry: An alternative and easy method to evaluate bone quality in people living with human immunodeficiency virus |
| Q90156322 | Reduction of Immune Activation and Partial Recovery of Staphylococcal Enterotoxin B-Induced Cytokine Production After Switching to an Integrase Strand Transfer Inhibitor-Containing Regimen: Results from an Observational Cohort Study |
| Q51147416 | Rethinking retention: Mapping interactions between multiple factors that influence long-term engagement in HIV care. |
| Q96122985 | Risk Factors for symptomatic HIV-associated Neurocognitive Disorder in adults aged 50 and over attending a HIV clinic in Tanzania |
| Q40050342 | Role of Connexin and Pannexin containing channels in HIV infection and NeuroAIDS. |
| Q90224924 | Stroke and Systemic Thromboembolism Prevention in People Living With Human Immunodeficiency Virus With Atrial Fibrillation: A Review of Its Implications for Clinical Practice |
| Q59812938 | Synaptic Connectivity in Medium Spiny Neurons of the Nucleus Accumbens: A Sex-Dependent Mechanism Underlying Apathy in the HIV-1 Transgenic Rat |
| Q92885360 | Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection |
| Q40087072 | Transplantation of the Patient with Human Immunodeficiency Virus |
| Q59352953 | Virucidal and Synergistic Activity of Polyphenol-Rich Extracts of Seaweeds against Measles Virus |
| Q91470325 | [HIV in Sub-Saharan Africa: Where Are We Today?] |
Search more.